Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.785
+0.005 (0.63%)
At close: Apr 28, 2026, 4:00 PM EDT
0.782
-0.003 (-0.42%)
After-hours: Apr 28, 2026, 5:36 PM EDT
Evogene Employees
Evogene had 52 employees as of December 31, 2025. The number of employees decreased by 65 or -55.56% compared to the previous year.
Employees
52
Change (1Y)
-65
Growth (1Y)
-55.56%
Revenue / Employee
$74,096
Profits / Employee
-$163,173
Market Cap
8.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| Imunon | 25 |
| Bolt Biotherapeutics | 23 |
| CalciMedica | 16 |
| Kiora Pharmaceuticals | 13 |
| Genprex | 13 |
| Aprea Therapeutics | 8 |
| Enveric Biosciences | 6 |
EVGN News
- 26 days ago - Evogene (EVGN) Faces Nasdaq Compliance Challenge Over Bid Price - GuruFocus
- 26 days ago - Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - PRNewsWire
- 4 weeks ago - Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - PRNewsWire
- 6 weeks ago - Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus
- 6 weeks ago - Q4 2025 Evogene Ltd Earnings Call Transcript - GuruFocus
- 7 weeks ago - Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - PRNewsWire
- 7 weeks ago - Evogene (EVGN) Focuses on Key Markets Following Strategic Shift - GuruFocus
- 7 weeks ago - Evogene Earnings Review: Q4 Summary - Benzinga